{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:09:37Z","timestamp":1768082977362,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T00:00:00Z","timestamp":1320624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T00:00:00Z","timestamp":1320624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/bmt.2011.208","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T12:23:59Z","timestamp":1320668639000},"page":"946-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results"],"prefix":"10.1038","volume":"47","author":[{"given":"J D","family":"Bowen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G H","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wundes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K R","family":"Maravilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T A","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Z","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Storb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B A","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G R","family":"Henstorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,7]]},"reference":[{"key":"BFbmt2011208_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175\u20131189.","journal-title":"Brain"},{"key":"BFbmt2011208_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1212\/WNL.0b013e3181b2a6ce","volume":"73","author":"SC Reingold","year":"2009","unstructured":"Reingold SC, Steiner JP, Polman CH, Cohen JA, Freedman MS, Kappos L et al. The challenge of follow-on biologics for treatment of multiple sclerosis (Review). Neurology 2009; 73: 552\u2013559.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/135245859900500104","volume":"5","author":"D Karussis","year":"1999","unstructured":"Karussis D, Vourka-Karussis U, Mizrachi-Koll R, Abramsky O . Acute\/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation. Mult Scler 1999; 5: 17\u201321.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"RA Nash","year":"2007","unstructured":"Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen C-S, Godwin JD et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007; 110: 1388\u20131396.","journal-title":"Blood"},{"key":"BFbmt2011208_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis [Erratum appears in Ann Rheum Dis. 2008 Feb;67(2):280]. Ann Rheum Dis 2008; 67: 98\u2013104.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011208_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527\u2013535.","journal-title":"JAMA"},{"key":"BFbmt2011208_CR7","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.22656","volume":"56","author":"DM Brinkman","year":"2007","unstructured":"Brinkman DM, de Kleer IM, Ten Cate R, Van Rossum MA, Bekkering WP, Fasth A et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56: 2410\u20132421.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011208_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/sj.bmt.1702153","volume":"25","author":"DW van Bekkum","year":"2000","unstructured":"van Bekkum DW . Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25: 357\u2013364.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011208_CR9","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","volume":"102","author":"RA Nash","year":"2003","unstructured":"Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park M-S et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364\u20132372.","journal-title":"Blood"},{"key":"BFbmt2011208_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clim.2004.07.006","volume":"113","author":"J Storek","year":"2004","unstructured":"Storek J, Zhao Z, Lin E, Berger T, McSweeney PA, Nash RA et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin Immunol 2004; 113: 285\u2013298.","journal-title":"Clin Immunol"},{"key":"BFbmt2011208_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227\u2013231.","journal-title":"Ann Neurol"},{"key":"BFbmt2011208_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (Usa) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907\u2013911.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444\u20131452.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/sj.bmt.1701257","volume":"21","author":"SD Rowley","year":"1998","unstructured":"Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T et al. Isolation of CD34+ cells from blood stem cell components using the Baxter isolex system. Bone Marrow Transplant 1998; 21: 1253\u20131262.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011208_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","volume":"62","author":"MS Freedman","year":"2005","unstructured":"Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005; 62: 865\u2013870.","journal-title":"Arch Neurol"},{"key":"BFbmt2011208_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BFbmt2011208_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2011208_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1083-8791(03)00228-3","volume":"9","author":"RA Nash","year":"2003","unstructured":"Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA et al. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 2003; 9: 583\u2013591.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011208_CR19","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","volume":"54","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54: 2147\u20132150.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0268-960X(03)00022-5","volume":"17","author":"A Fassas","year":"2003","unstructured":"Fassas A, Kimiskidis VK . Stem cell transplantation for multiple sclerosis: what is the evidence? (Review). Blood Rev 2003; 17: 233\u2013240.","journal-title":"Blood Rev"},{"key":"BFbmt2011208_CR21","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/WNL.0b013e318211c537","volume":"76","author":"A Fassas","year":"2011","unstructured":"Fassas A, Kimiskidis VK, Sakellari I, Kapinas K, Anagnostopoulos A, Tsimourtou V et al. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology 2011; 76: 1066\u20131070.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR22","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood-2004-08-3205","volume":"105","author":"R Saccardi","year":"2005","unstructured":"Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601\u20132607.","journal-title":"Blood"},{"key":"BFbmt2011208_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1532\/IJH97.A10516","volume":"84","author":"L Su","year":"2006","unstructured":"Su L, Xu J, Ji BX, Wan SG, Lu CY, Dong HQ et al. Autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Int J Hematol 2006; 84: 276\u2013281.","journal-title":"Int J Hematol"},{"key":"BFbmt2011208_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.exphem.2008.03.001","volume":"36","author":"YL Shevchenko","year":"2008","unstructured":"Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA et al. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Exp Hematol 2008; 36: 922\u2013928.","journal-title":"Exp Hematol"},{"key":"BFbmt2011208_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/1352458510364538","volume":"16","author":"E Krasulova","year":"2010","unstructured":"Krasulova E, Trneny M, Kozak T, Vackova B, Pohlreich D, Kemlink D et al. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Mult Scler 2010; 16: 685\u2013693.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR26","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/1352458506071301","volume":"12","author":"R Saccardi","year":"2006","unstructured":"Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 2006; 12: 814\u2013823.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR27","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","volume":"102","author":"RK Burt","year":"2003","unstructured":"Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102: 2373\u20132378.","journal-title":"Blood"},{"key":"BFbmt2011208_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1191\/1352458505ms1181cr","volume":"11","author":"GL Mancardi","year":"2005","unstructured":"Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 2005; 11: 367\u2013371.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1352458508096875","volume":"15","author":"J Fagius","year":"2009","unstructured":"Fagius J, Lundgren J, Oberg G . Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 2009; 15: 229\u2013237.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1352458507082604","volume":"14","author":"V Kimiskidis","year":"2008","unstructured":"Kimiskidis V, Sakellari I, Tsimourtou V, Kapina V, Papagiannopoulos S, Kazis D et al. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. Mult Scler 2008; 14: 278\u2013283.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study [Erratum appears in Lancet Neurol. 2009 Apr;8(4):309]. Lancet Neurol 2009; 8: 244\u2013253.","journal-title":"Lancet Neurol"},{"key":"BFbmt2011208_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1714","volume":"14","author":"B Obermeier","year":"2008","unstructured":"Obermeier B, Mentele R, Malotka J, Kellermann J, Kumpfel T, Wekerle H et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008; 14: 688\u2013693.","journal-title":"Nat Med"},{"key":"BFbmt2011208_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S1083-8791(00)70066-8","volume":"6","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 6: 563\u2013575.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011208_CR34","first-page":"306","volume":"88","author":"E Carreras","year":"2003","unstructured":"Carreras E, Saiz A, Marin P, Martinez C, Rovira M, Villamor N et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306\u2013314.","journal-title":"Haematologica"},{"key":"BFbmt2011208_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/jnnp.2007.133520","volume":"79","author":"T Mondria","year":"2008","unstructured":"Mondria T, Lamers CH, te Boekhorst PA, Gratama JW, Hintzen RQ . Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 1013\u20131015.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFbmt2011208_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/1352458506073502","volume":"13","author":"E Portaccio","year":"2007","unstructured":"Portaccio E, Amato MP, Siracusa G, Pagliai F, Sorbi S, Guidi S et al. Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases. Mult Scler 2007; 13: 676\u2013678.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/brain\/awl370","volume":"130","author":"I Metz","year":"2007","unstructured":"Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 2007; 130: 1254\u20131262.","journal-title":"Brain"},{"key":"BFbmt2011208_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jnnp.2005.063883","volume":"77","author":"JP Samijn","year":"2006","unstructured":"Samijn JP, te Boekhorst PA, Mondria T, van Doorn PA, Flach HZ, van der Meche FG et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 46\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFbmt2011208_CR39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1352458510383609","volume":"17","author":"JT Reston","year":"2011","unstructured":"Reston JT, Uhl S, Treadwell JR, Nash RA, Schoelles K . Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review. Mult Scler 2011; 17: 204\u2013213.","journal-title":"Mult Scler"},{"key":"BFbmt2011208_CR40","first-page":"1275","volume":"17","author":"HR Jager","year":"1996","unstructured":"Jager HR, Williams EJ, Savage DG, Rule SA, Hajnal JV, Sikora K et al. Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia. Am J Neurorad 1996; 17: 1275\u20131282.","journal-title":"Am J Neurorad"},{"key":"BFbmt2011208_CR41","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1212\/01.wnl.0000219816.44094.f8","volume":"66","author":"JT Chen","year":"2006","unstructured":"Chen JT, Collins DL, Atkins HL, Freedman MS, Galal A, Arnold DL et al. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 2006; 66: 1935\u20131937.","journal-title":"Neurology"},{"key":"BFbmt2011208_CR42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1177\/1352458507076982","volume":"13","author":"L Roccatagliata","year":"2007","unstructured":"Roccatagliata L, Rocca M, Valsasina P, Bonzano L, Sormani M, Saccardi R et al. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. Mult Scler 2007; 13: 1068\u20131070.","journal-title":"Mult Scler"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2011208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2011208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:40:14Z","timestamp":1648046414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2011208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFbmt2011208"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2011.208","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,7]]},"assertion":[{"value":"3 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}